BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Best of BioWorld: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
New DPP IV inhibitors reported by Merck & Co.
March 18, 2011
Genfit and sanofi-aventis sign new agreement to develop drugs for metabolic disorders
March 17, 2011
Amylin and Takeda suspend pramlintide/metreleptin trial in obesity
March 17, 2011
Chinese health authorities approve Novo Nordisk's Victoza for type 2 diabetes
March 16, 2011
Boehringer Ingelheim obtains rights to Acuform technology and Glumetza data
March 16, 2011
Unigene begins dosing in phase II study of oral parathyroid hormone for osteoporosis
March 16, 2011
Biodel selects two ultrarapid-acting insulin formulations for clinical development
March 16, 2011
Omthera Pharma raises funds for phase III Epanova trial
March 15, 2011
First oral LH receptor agonist induces ovulation in healthy women
March 15, 2011
Phase III DEFEND-1 trial in type 1 diabetes does not meet primary endpoint
March 14, 2011
Previous
1
2
…
633
634
635
636
637
638
639
640
641
…
1792
1793
Next
RSS